Related Experiment Videos
Cardiac markers and point-of-care testing: a perfect fit.
R G Males1, J Stephenson, P Harris
1Response Biomedical Group, Burnaby, British Columbia.
Critical Care Nursing Quarterly
|March 1, 2002
Summary
Point-of-care testing (POCT) for acute myocardial infarction (AMI) offers reliable results comparable to lab tests. This technology can improve chest pain diagnosis, but user confidence is key for widespread adoption.
Area of Science:
- Cardiology
- Biochemistry
- Medical Diagnostics
Background:
- Biochemical markers are crucial for diagnosing acute myocardial infarction (AMI), especially when electrocardiograms (ECG) are inconclusive.
- Point-of-care testing (POCT) enables diagnostic assays at the patient's location, facilitating rapid results.
Purpose of the Study:
- To evaluate the role and performance of POCT for biochemical markers in diagnosing AMI.
- To assess the potential of POCT to become the standard of care for chest discomfort evaluation.
Main Methods:
- Review of currently available POCT assays for cardiac markers like myoglobin, CK-MB, troponin I, and troponin T.
- Comparison of diagnostic performance between POCT and traditional laboratory-based assays.
Main Results:
- POCT assays for cardiac markers demonstrate diagnostic performance comparable to laboratory methods.
- POCT offers a viable alternative for the rapid assessment of over 6 million US patients presenting with chest discomfort annually.
Conclusions:
- POCT for cardiac markers is a reliable diagnostic tool for AMI, matching laboratory assay performance.
- Widespread adoption of POCT for chest pain evaluation hinges on user-friendliness and confidence in test results.